Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
Clinical trial NCT01811498 · COMPLETED
Trial details
- NCT number
- NCT01811498
- Sponsor
- Northwell Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2021-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.